SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5t2z'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1C6Y_B_MK1B524_1
(PROTEIN (PROTEASE))		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ILE A  47
ILE A  50
PRO A  81
ILE A  84
 None
 0.86A 1c6yA-5t2zA:
19.2		 1c6yA-5t2zA:
83.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1C6Y_B_MK1B524_1
(PROTEIN (PROTEASE))		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 11 LEU A  23
ASP A  25
ALA A  28
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.65A 1c6yA-5t2zA:
19.2		 1c6yA-5t2zA:
83.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1C6Y_B_MK1B524_2
(PROTEIN (PROTEASE))		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
ILE A  84
 None
 0.46A 1c6yB-5t2zA:
18.7		 1c6yB-5t2zA:
83.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1C6Y_B_MK1B524_2
(PROTEIN (PROTEASE))		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  50
THR A  80
ILE A  84
 None
 0.61A 1c6yB-5t2zA:
18.7		 1c6yB-5t2zA:
83.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1C6Y_B_MK1B524_2
(PROTEIN (PROTEASE))		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
THR A  80
PRO A  81
ILE A  84
 None
 0.67A 1c6yB-5t2zA:
18.7		 1c6yB-5t2zA:
83.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1C6Z_B_ROCB505_1
(PROTEIN (PROTEASE))		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
ILE A  84
 None
 0.47A 1c6zA-5t2zA:
19.0		 1c6zA-5t2zA:
83.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1C6Z_B_ROCB505_1
(PROTEIN (PROTEASE))		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
ILE A  47
GLY A  49
PRO A  81
ILE A  84
 None
 0.59A 1c6zA-5t2zA:
19.0		 1c6zA-5t2zA:
83.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1C6Z_B_ROCB505_2
(PROTEIN (PROTEASE))		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 ARG A   8
ASP A  25
GLY A  27
VAL A  32
ILE A  47
ILE A  50
ILE A  84
 None
 0.53A 1c6zB-5t2zA:
18.9		 1c6zB-5t2zA:
83.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1C6Z_B_ROCB505_2
(PROTEIN (PROTEASE))		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 ARG A   8
ASP A  25
GLY A  27
VAL A  32
ILE A  47
PRO A  81
ILE A  84
 None
 0.82A 1c6zB-5t2zA:
18.9		 1c6zB-5t2zA:
83.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1C6Z_B_ROCB505_2
(PROTEIN (PROTEASE))		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  47
GLY A  49
ILE A  50
ILE A  84
 None
 0.43A 1c6zB-5t2zA:
18.9		 1c6zB-5t2zA:
83.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1C6Z_B_ROCB505_2
(PROTEIN (PROTEASE))		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  47
GLY A  49
PRO A  81
ILE A  84
 None
 0.57A 1c6zB-5t2zA:
18.9		 1c6zB-5t2zA:
83.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1D4S_A_TPVA201_1
(PROTEIN (HIV-1
PROTEASE))		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  47
GLY A  49
PRO A  81
 None
 0.55A 1d4sA-5t2zA:
19.9		 1d4sA-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1D4S_A_TPVA201_1
(PROTEIN (HIV-1
PROTEASE))		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
 None
 1.39A 1d4sA-5t2zA:
19.9		 1d4sA-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1D4Y_A_TPVA501_1
(PROTEIN (HIV-1
PROTEASE))		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 10 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
 None
 0.45A 1d4yA-5t2zA:
20.0		 1d4yA-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1D4Y_A_TPVA501_1
(PROTEIN (HIV-1
PROTEASE))		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 10 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.49A 1d4yA-5t2zA:
20.0		 1d4yA-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1FB7_A_ROCA100_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ASP A  25
ALA A  28
ASP A  29
VAL A  48
GLY A  49
ILE A  50
 None
 1.27A 1fb7A-5t2zA:
19.7		 1fb7A-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1FB7_A_ROCA100_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  48
GLY A  49
ILE A  50
THR A  80
ILE A  84
 None
 0.58A 1fb7A-5t2zA:
19.7		 1fb7A-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1FB7_A_ROCA100_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  48
GLY A  49
THR A  80
PRO A  81
ILE A  84
 None
 0.52A 1fb7A-5t2zA:
19.7		 1fb7A-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HPV_B_478B200_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 9 LEU A  23
ASP A  25
GLY A  27
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.54A 1hpvA-5t2zA:
20.3		 1hpvA-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HPV_B_478B200_2
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 9 ASP A  25
ALA A  28
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.36A 1hpvB-5t2zA:
20.4		 1hpvB-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSG_B_MK1B902_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 10 ARG A   8
LEU A  23
ASP A  25
ALA A  28
VAL A  32
ILE A  47
PRO A  81
ILE A  84
 None
 0.65A 1hsgA-5t2zA:
19.5		 1hsgA-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSG_B_MK1B902_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 10 LEU A  23
ASP A  25
ALA A  28
VAL A  32
ILE A  47
GLY A  49
PRO A  81
ILE A  84
 None
 0.43A 1hsgA-5t2zA:
19.5		 1hsgA-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSG_B_MK1B902_2
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  47
GLY A  49
PRO A  81
ILE A  84
 None
 0.39A 1hsgB-5t2zA:
19.9		 1hsgB-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSH_A_MK1A401_2
(HIV-II PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 ALA A  22
ILE A  66
GLY A  86
ILE A  15
ILE A  13
 None
 0.89A 1hshB-5t2zA:
18.7		 1hshB-5t2zA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSH_A_MK1A401_2
(HIV-II PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 9 ASP A  25
ALA A  28
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.69A 1hshB-5t2zA:
18.7		 1hshB-5t2zA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSH_C_MK1C402_1
(HIV-II PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
 0.48A 1hshC-5t2zA:
19.1		 1hshC-5t2zA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSH_C_MK1C402_1
(HIV-II PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 0.40A 1hshC-5t2zA:
19.1		 1hshC-5t2zA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXB_A_ROCA100_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
ILE A  84
 None
 0.48A 1hxbA-5t2zA:
20.2		 1hxbA-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXB_A_ROCA100_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  47
GLY A  49
PRO A  81
ILE A  84
 None
 0.45A 1hxbA-5t2zA:
20.2		 1hxbA-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXB_A_ROCA100_3
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
ILE A  47
ILE A  50
PRO A  81
ILE A  84
 None
 0.57A 1hxbB-5t2zA:
20.3		 1hxbB-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXB_A_ROCA100_3
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.29A 1hxbB-5t2zA:
20.3		 1hxbB-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXB_A_ROCA100_3
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.47A 1hxbB-5t2zA:
20.3		 1hxbB-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXW_B_RITB301_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 9 ASP A  25
GLY A  27
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.49A 1hxwA-5t2zA:
20.0		 1hxwA-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXW_B_RITB301_2
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 11 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
 None
 0.64A 1hxwB-5t2zA:
19.7		 1hxwB-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1K6C_B_MK1B902_1
(POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 ARG A   8
LEU A  23
ASP A  25
ALA A  28
VAL A  32
PRO A  81
 None
 0.75A 1k6cA-5t2zA:
20.0		 1k6cA-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1K6C_B_MK1B902_1
(POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 10 LEU A  23
ASP A  25
ALA A  28
VAL A  32
ILE A  47
GLY A  49
PRO A  81
 None
 0.48A 1k6cA-5t2zA:
20.0		 1k6cA-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1K6C_B_MK1B902_2
(POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 12 ARG A   8
ASP A  25
GLY A  27
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
 None
 0.64A 1k6cB-5t2zA:
20.0		 1k6cB-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1K6C_B_MK1B902_2
(POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
 None
 0.49A 1k6cB-5t2zA:
20.0		 1k6cB-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1MUI_B_AB1B100_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.50A 1muiA-5t2zA:
19.8		 1muiA-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1N49_B_RITB301_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 7 ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.47A 1n49A-5t2zA:
19.4		 1n49A-5t2zA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1N49_B_RITB301_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 11 ARG A   8
GLY A  27
ALA A  28
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.83A 1n49B-5t2zA:
19.3		 1n49B-5t2zA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1N49_D_RITD401_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 11 ARG A   8
GLY A  27
ALA A  28
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.78A 1n49C-5t2zA:
19.2		 1n49C-5t2zA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1N49_D_RITD401_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 6 ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.57A 1n49D-5t2zA:
19.5		 1n49D-5t2zA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1OHR_A_1UNA201_1
(ASPARTYLPROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 1.46A 1ohrA-5t2zA:
20.0		 1ohrA-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1OHR_A_1UNA201_1
(ASPARTYLPROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
THR A  80
PRO A  81
ILE A  84
 None
 0.66A 1ohrA-5t2zA:
20.0		 1ohrA-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1OHR_A_1UNA201_2
(ASPARTYLPROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 9 LEU A  23
ASP A  25
VAL A  32
ILE A  47
GLY A  49
ILE A  50
ILE A  84
 None
 0.46A 1ohrB-5t2zA:
18.9		 1ohrB-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1OHR_A_1UNA201_2
(ASPARTYLPROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 9 LEU A  23
ASP A  25
VAL A  32
ILE A  47
GLY A  49
PRO A  81
ILE A  84
 None
 0.66A 1ohrB-5t2zA:
18.9		 1ohrB-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDT_B_MK1B902_1
(PROTEASE RETROPEPSIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 ARG A   8
LEU A  23
ASP A  25
GLY A  49
PRO A  81
ILE A  84
 None
 0.87A 1sdtA-5t2zA:
20.1		 1sdtA-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDT_B_MK1B902_1
(PROTEASE RETROPEPSIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 10 LEU A  23
ASP A  25
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.57A 1sdtA-5t2zA:
20.1		 1sdtA-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDT_B_MK1B902_2
(PROTEASE RETROPEPSIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  47
GLY A  49
PRO A  81
ILE A  84
 None
 0.55A 1sdtB-5t2zA:
20.1		 1sdtB-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDT_B_MK1B902_2
(PROTEASE RETROPEPSIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.58A 1sdtB-5t2zA:
20.1		 1sdtB-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDU_B_MK1B902_1
(PROTEASE RETROPEPSIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 11 LEU A  23
ASP A  25
ALA A  28
ILE A  47
GLY A  49
ILE A  50
ILE A  84
 None
 0.54A 1sduA-5t2zA:
20.0		 1sduA-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDU_B_MK1B902_1
(PROTEASE RETROPEPSIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 11 LEU A  23
ASP A  25
ALA A  28
ILE A  47
GLY A  49
PRO A  81
ILE A  84
 None
 0.61A 1sduA-5t2zA:
20.0		 1sduA-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDU_B_MK1B902_2
(PROTEASE RETROPEPSIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.55A 1sduB-5t2zA:
19.9		 1sduB-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDV_B_MK1B902_1
(PROTEASE RETROPEPSIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 10 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ILE A  47
PRO A  81
ILE A  84
 None
 0.59A 1sdvA-5t2zA:
20.2		 1sdvA-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDV_B_MK1B902_1
(PROTEASE RETROPEPSIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
GLY A  49
PRO A  81
ILE A  84
 None
 0.82A 1sdvA-5t2zA:
20.2		 1sdvA-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDV_B_MK1B902_1
(PROTEASE RETROPEPSIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 10 LEU A  23
ASP A  25
ALA A  28
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.55A 1sdvA-5t2zA:
20.2		 1sdvA-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDV_B_MK1B902_2
(PROTEASE RETROPEPSIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		11 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.60A 1sdvB-5t2zA:
20.1		 1sdvB-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SGU_B_MK1B2632_2
(POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ALA A  22
 None
 1.31A 1sguB-5t2zA:
21.2		 1sguB-5t2zA:
83.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SGU_B_MK1B2632_2
(POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
PRO A  81
 None
 0.49A 1sguB-5t2zA:
21.2		 1sguB-5t2zA:
83.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SGU_B_MK1B2632_2
(POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
GLY A  49
ILE A  50
PRO A  81
 None
 0.47A 1sguB-5t2zA:
21.2		 1sguB-5t2zA:
83.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SH9_B_RITB301_2
(POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 ARG A   8
ASP A  25
GLY A  27
ASP A  30
ILE A  47
PRO A  81
 None
 1.11A 1sh9B-5t2zA:
20.9		 1sh9B-5t2zA:
83.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SH9_B_RITB301_2
(POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 10 ASP A  25
GLY A  27
ASP A  30
ILE A  47
GLY A  49
ILE A  50
PRO A  81
 None
 0.42A 1sh9B-5t2zA:
20.9		 1sh9B-5t2zA:
83.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T3R_A_017A1200_1
(PROTEASE RETROPEPSIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.19A 1t3rA-5t2zA:
20.0		 1t3rA-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T3R_A_017A1200_1
(PROTEASE RETROPEPSIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
 None
 0.45A 1t3rA-5t2zA:
20.0		 1t3rA-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T3R_A_017A1200_2
(PROTEASE RETROPEPSIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 11 LEU A  23
ASP A  25
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.57A 1t3rB-5t2zA:
19.6		 1t3rB-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T3R_A_017A1200_2
(PROTEASE RETROPEPSIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 11 LEU A  23
ASP A  25
ALA A  28
VAL A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.43A 1t3rB-5t2zA:
19.6		 1t3rB-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T7I_A_017A200_1
(POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.24A 1t7iA-5t2zA:
19.9		 1t7iA-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T7I_A_017A200_1
(POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
 None
 0.45A 1t7iA-5t2zA:
19.9		 1t7iA-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T7I_A_017A200_2
(POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 7 ASP A  25
ALA A  28
ASP A  30
VAL A  32
 None
 0.45A 1t7iB-5t2zA:
19.7		 1t7iB-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T7I_A_017A200_2
(POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 7 ASP A  25
ALA A  28
VAL A  32
GLY A  49
ILE A  50
 None
 0.21A 1t7iB-5t2zA:
19.7		 1t7iB-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T7J_A_478A200_1
(POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  50
THR A  80
 None
 1.37A 1t7jA-5t2zA:
19.9		 1t7jA-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T7J_A_478A200_1
(POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.24A 1t7jA-5t2zA:
19.9		 1t7jA-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T7J_A_478A200_1
(POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
 None
 0.44A 1t7jA-5t2zA:
19.9		 1t7jA-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T7J_A_478A200_2
(POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 7 ASP A  25
ALA A  28
ASP A  30
VAL A  32
 None
 0.47A 1t7jB-5t2zA:
19.6		 1t7jB-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T7J_A_478A200_2
(POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 7 ASP A  25
ALA A  28
VAL A  32
GLY A  49
ILE A  50
 None
 0.27A 1t7jB-5t2zA:
19.6		 1t7jB-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AOF_C_FRDC305_1
(POL POLYPROTEIN
PEPTIDE INHIBITOR)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 5 ASP A  25
GLY A  49
PRO A  81
ILE A  84
 None
 0.34A 2aofA-5t2zA:
20.2		 2aofA-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AOF_C_FRDC305_2
(POL POLYPROTEIN
PEPTIDE INHIBITOR)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 5 LEU A  23
ASP A  25
PRO A  81
ILE A  84
 None
 0.22A 2aofB-5t2zA:
20.2		 2aofB-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AOH_C_FRDC305_1
(POL POLYPROTEIN
PEPTIDE INHIBITOR)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 5 LEU A  23
ASP A  25
GLY A  49
PRO A  81
 None
 0.51A 2aohA-5t2zA:
20.2		 2aohA-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AOI_C_FRDC305_1
(POL POLYPROTEIN
PEPTIDE INHIBITOR)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 5 ASP A  25
GLY A  49
PRO A  81
ILE A  84
 None
 0.43A 2aoiA-5t2zA:
20.1		 2aoiA-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AOI_C_FRDC305_2
(POL POLYPROTEIN
PEPTIDE INHIBITOR)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 5 LEU A  23
ASP A  25
PRO A  81
ILE A  84
 None
 0.26A 2aoiB-5t2zA:
20.2		 2aoiB-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AOJ_C_FRDC305_1
(POL POLYPROTEIN
PEPTIDE INHIBITOR)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 5 LEU A  23
ASP A  25
GLY A  49
PRO A  81
 None
 0.46A 2aojA-5t2zA:
20.1		 2aojA-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AQU_B_DR7B300_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 10 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.39A 2aquA-5t2zA:
20.3		 2aquA-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AQU_B_DR7B300_2
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 11 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.45A 2aquB-5t2zA:
20.3		 2aquB-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVO_B_MK1B902_1
(POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 9 ARG A   8
LEU A  23
ASP A  25
ILE A  47
ILE A  50
PRO A  81
ILE A  84
 None
 0.87A 2avoA-5t2zA:
19.7		 2avoA-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVO_B_MK1B902_1
(POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 9 LEU A  23
ASP A  25
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.71A 2avoA-5t2zA:
19.7		 2avoA-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVO_B_MK1B902_2
(POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  47
GLY A  49
PRO A  81
ILE A  84
 None
 0.46A 2avoB-5t2zA:
20.0		 2avoB-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVS_B_MK1B902_1
(POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  84
 None
 0.43A 2avsA-5t2zA:
20.1		 2avsA-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVS_B_MK1B902_3
(POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  47
GLY A  49
PRO A  81
ILE A  84
 None
 0.48A 2avsB-5t2zA:
19.9		 2avsB-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_A_MK1A901_1
(POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ILE A  50
 None
 0.56A 2avvA-5t2zA:
19.9		 2avvA-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_A_MK1A901_1
(POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
GLY A  49
ILE A  84
 None
 0.68A 2avvA-5t2zA:
19.9		 2avvA-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_A_MK1A901_1
(POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
ILE A  47
GLY A  49
ILE A  50
ILE A  84
 None
 0.47A 2avvA-5t2zA:
19.9		 2avvA-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_E_MK1E902_1
(POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
PRO A  81
 None
 0.77A 2avvD-5t2zA:
19.9		 2avvD-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_E_MK1E902_1
(POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
ILE A  47
GLY A  49
PRO A  81
ILE A  84
 None
 0.51A 2avvD-5t2zA:
19.9		 2avvD-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_E_MK1E902_3
(POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
ILE A  84
 None
 0.49A 2avvE-5t2zA:
20.0		 2avvE-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_E_MK1E902_3
(POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
PRO A  81
ILE A  84
 None
 0.48A 2avvE-5t2zA:
20.0		 2avvE-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2B60_B_RITB100_1
(GAG-POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  47
PRO A  81
ILE A  84
 None
 0.93A 2b60A-5t2zA:
21.1		 2b60A-5t2zA:
83.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2B60_B_RITB100_1
(GAG-POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.38A 2b60A-5t2zA:
21.1		 2b60A-5t2zA:
83.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2B60_B_RITB100_1
(GAG-POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  47
GLY A  49
PRO A  81
ILE A  84
 None
 0.46A 2b60A-5t2zA:
21.1		 2b60A-5t2zA:
83.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2B60_B_RITB100_2
(GAG-POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 11 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.46A 2b60B-5t2zA:
21.0		 2b60B-5t2zA:
83.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2B7Z_B_MK1B200_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
ASP A  25
GLY A  27
ILE A  50
PRO A  81
 None
 0.64A 2b7zA-5t2zA:
20.9		 2b7zA-5t2zA:
82.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2B7Z_B_MK1B200_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ALA A  22
 None
 1.29A 2b7zA-5t2zA:
20.9		 2b7zA-5t2zA:
82.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2B7Z_B_MK1B200_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
PRO A  81
 None
 0.42A 2b7zA-5t2zA:
20.9		 2b7zA-5t2zA:
82.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2B7Z_B_MK1B200_2
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
GLY A  49
ILE A  50
PRO A  81
 None
 0.54A 2b7zB-5t2zA:
20.9		 2b7zB-5t2zA:
82.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2B7Z_B_MK1B200_2
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ALA A  22
 None
 1.31A 2b7zB-5t2zA:
20.9		 2b7zB-5t2zA:
82.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2B7Z_B_MK1B200_2
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
PRO A  81
 None
 0.49A 2b7zB-5t2zA:
20.9		 2b7zB-5t2zA:
82.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2BPX_B_MK1B902_2
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  47
GLY A  49
PRO A  81
ILE A  84
 None
 0.58A 2bpxB-5t2zA:
19.4		 2bpxB-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F80_B_017B301_1
(POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
 None
 1.35A 2f80A-5t2zA:
20.1		 2f80A-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F80_B_017B301_1
(POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.34A 2f80A-5t2zA:
20.1		 2f80A-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F80_B_017B301_2
(POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.27A 2f80B-5t2zA:
20.2		 2f80B-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F81_A_017A302_1
(POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		11 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.34A 2f81A-5t2zA:
20.3		 2f81A-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F81_A_017A302_2
(POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.24A 2f81B-5t2zA:
20.2		 2f81B-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F81_A_017A302_2
(POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		11 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.36A 2f81B-5t2zA:
20.2		 2f81B-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F8G_B_017B401_1
(POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  84
 None
 0.28A 2f8gA-5t2zA:
20.2		 2f8gA-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2FXD_A_DR7A102_1
(POL PROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 ARG A   8
ILE A  10
ASP A  25
ALA A  28
ASP A  30
GLY A  49
 None
 1.49A 2fxdA-5t2zA:
18.4		 2fxdA-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2FXD_A_DR7A102_1
(POL PROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 11 ARG A   8
ILE A  10
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 0.49A 2fxdA-5t2zA:
18.4		 2fxdA-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2FXD_A_DR7A102_2
(POL PROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 7 ARG A   8
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
 None
 0.54A 2fxdB-5t2zA:
20.1		 2fxdB-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2FXD_A_DR7A102_2
(POL PROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 7 ARG A   8
ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
 None
 1.47A 2fxdB-5t2zA:
20.1		 2fxdB-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2FXE_A_DR7A102_2
(POL PROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 11 ARG A   8
ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 1.45A 2fxeB-5t2zA:
19.8		 2fxeB-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2FXE_A_DR7A102_2
(POL PROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 11 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.49A 2fxeB-5t2zA:
19.8		 2fxeB-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS1_A_017A201_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.35A 2hs1A-5t2zA:
19.5		 2hs1A-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS1_A_017A201_2
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.54A 2hs1B-5t2zA:
20.2		 2hs1B-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS1_B_017B203_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 7 TRP A  42
PRO A  44
ARG A  57
GLY A  78
 None
 0.29A 2hs1B-5t2zA:
20.2		 2hs1B-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS1_B_017B203_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 7 TRP A  42
PRO A  44
LYS A  55
ARG A  57
 None
 0.67A 2hs1B-5t2zA:
20.2		 2hs1B-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS2_A_017A201_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.51A 2hs2A-5t2zA:
19.5		 2hs2A-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS2_A_017A201_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.39A 2hs2B-5t2zA:
20.3		 2hs2B-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS2_B_017B203_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 6 TRP A  42
PRO A  44
LEU A  46
ARG A  57
GLY A  78
 None
 0.43A 2hs2B-5t2zA:
20.3		 2hs2B-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS2_B_017B203_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 6 TRP A  42
PRO A  44
LEU A  46
LYS A  55
ARG A  57
 None
 0.67A 2hs2B-5t2zA:
20.3		 2hs2B-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IDW_B_017B401_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 11 LEU A  23
ASP A  25
ALA A  28
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.46A 2idwA-5t2zA:
19.8		 2idwA-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IDW_B_017B401_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 9 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
ILE A  84
 None
 1.17A 2idwB-5t2zA:
19.8		 2idwB-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IDW_B_017B401_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
 0.44A 2idwB-5t2zA:
19.8		 2idwB-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IEN_B_017B402_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
 None
 0.54A 2ienB-5t2zA:
20.2		 2ienB-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IEN_B_017B402_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
ILE A  84
 None
 0.42A 2ienB-5t2zA:
20.2		 2ienB-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IEO_A_017A402_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.25A 2ieoB-5t2zA:
20.3		 2ieoB-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IEO_A_017A402_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
 None
 1.41A 2ieoB-5t2zA:
20.3		 2ieoB-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IEO_A_017A402_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
 None
 0.35A 2ieoB-5t2zA:
20.3		 2ieoB-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMY_A_ROCA401_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 ARG A   8
ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 1.45A 2nmyA-5t2zA:
19.2		 2nmyA-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMY_A_ROCA401_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		12 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
THR A  80
PRO A  81
ILE A  84
 None
 0.55A 2nmyA-5t2zA:
19.2		 2nmyA-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMY_A_ROCA401_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		11 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.43A 2nmyB-5t2zA:
19.4		 2nmyB-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMZ_B_ROCB401_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		3 / 3 ARG A   8
VAL A  32
THR A  80
 None
 0.37A 2nmzA-5t2zA:
19.8		 2nmzA-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNK_A_ROCA401_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.33A 2nnkA-5t2zA:
19.8		 2nnkA-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNK_A_ROCA401_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
 None
 0.45A 2nnkA-5t2zA:
19.8		 2nnkA-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNK_A_ROCA401_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
PRO A  81
 None
 0.50A 2nnkA-5t2zA:
19.8		 2nnkA-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNK_A_ROCA401_3
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
ASP A  29
GLY A  49
ILE A  50
PRO A  81
 None
 1.37A 2nnkB-5t2zA:
20.0		 2nnkB-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNK_A_ROCA401_3
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
PRO A  81
 None
 0.55A 2nnkB-5t2zA:
20.0		 2nnkB-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNP_A_ROCA401_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
THR A  80
 None
 0.64A 2nnpA-5t2zA:
19.7		 2nnpA-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNP_A_ROCA401_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
THR A  80
PRO A  81
 None
 0.67A 2nnpA-5t2zA:
19.7		 2nnpA-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNP_A_ROCA401_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
 None
 0.57A 2nnpB-5t2zA:
19.7		 2nnpB-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4K_A_DR7A301_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.46A 2o4kA-5t2zA:
20.1		 2o4kA-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4K_A_DR7A301_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
 None
 1.49A 2o4kA-5t2zA:
20.1		 2o4kA-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4L_A_TPVA403_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
PRO A  81
ILE A  84
 None
 0.58A 2o4lA-5t2zA:
20.2		 2o4lA-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4P_A_TPVA300_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
PRO A  81
 None
 0.58A 2o4pA-5t2zA:
20.0		 2o4pA-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4P_A_TPVA300_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
 None
 1.44A 2o4pA-5t2zA:
20.0		 2o4pA-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4P_A_TPVA300_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 9 ARG A   8
LEU A  23
ASP A  25
ALA A  28
VAL A  32
GLY A  49
ILE A  50
ILE A  84
 None
 0.52A 2o4pB-5t2zA:
19.9		 2o4pB-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4S_A_AB1A400_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		11 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.46A 2o4sA-5t2zA:
20.0		 2o4sA-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4S_A_AB1A400_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
ASP A  25
GLY A  27
PRO A  81
ILE A  84
 None
 0.55A 2o4sB-5t2zA:
20.0		 2o4sB-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4S_A_AB1A400_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.52A 2o4sB-5t2zA:
20.0		 2o4sB-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PYM_A_1UNA1001_1
(PROTEASE RETROPEPSIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  49
ILE A  50
ILE A  84
 None
 0.46A 2pymA-5t2zA:
20.3		 2pymA-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PYM_A_1UNA1001_1
(PROTEASE RETROPEPSIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  49
PRO A  81
ILE A  84
 None
 0.50A 2pymA-5t2zA:
20.3		 2pymA-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PYM_A_1UNA1001_2
(PROTEASE RETROPEPSIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
ILE A  47
GLY A  49
ILE A  50
ILE A  84
 None
 0.45A 2pymB-5t2zA:
20.2		 2pymB-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PYM_A_1UNA1001_2
(PROTEASE RETROPEPSIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
ILE A  47
GLY A  49
PRO A  81
ILE A  84
 None
 0.50A 2pymB-5t2zA:
20.2		 2pymB-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PYN_A_1UNA1001_1
(PROTEASE RETROPEPSIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  49
ILE A  50
ILE A  84
 None
 0.45A 2pynA-5t2zA:
20.5		 2pynA-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PYN_A_1UNA1001_1
(PROTEASE RETROPEPSIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  49
PRO A  81
ILE A  84
 None
 0.48A 2pynA-5t2zA:
20.5		 2pynA-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PYN_A_1UNA1001_2
(PROTEASE RETROPEPSIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
ILE A  47
GLY A  49
ILE A  50
ILE A  84
 None
 0.43A 2pynB-5t2zA:
20.5		 2pynB-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q5K_A_AB1A201_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 9 ASP A  25
ALA A  28
ASP A  29
VAL A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.39A 2q5kA-5t2zA:
19.6		 2q5kA-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q5K_A_AB1A201_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 9 ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 1.38A 2q5kA-5t2zA:
19.6		 2q5kA-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q5K_A_AB1A201_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  30
ILE A  50
PRO A  81
 None
 0.72A 2q5kB-5t2zA:
20.0		 2q5kB-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q5K_A_AB1A201_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
 None
 0.62A 2q5kB-5t2zA:
20.0		 2q5kB-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q63_A_1UNA1001_3
(PROTEASE RETROPEPSIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
ILE A  47
GLY A  49
ILE A  50
ILE A  84
 None
 0.41A 2q63B-5t2zA:
20.4		 2q63B-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q63_A_1UNA1001_3
(PROTEASE RETROPEPSIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
ILE A  47
GLY A  49
PRO A  81
ILE A  84
 None
 0.48A 2q63B-5t2zA:
20.4		 2q63B-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q64_B_1UNB1001_1
(PROTEASE RETROPEPSIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		11 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.46A 2q64A-5t2zA:
20.4		 2q64A-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q64_B_1UNB1001_4
(PROTEASE RETROPEPSIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		3 / 3 ASP A  29
THR A  80
PRO A  81
 None
 0.23A 2q64B-5t2zA:
20.4		 2q64B-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QAK_A_1UNA1001_3
(PROTEASE RETROPEPSIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
ILE A  47
GLY A  49
ILE A  50
ILE A  84
 None
 0.44A 2qakB-5t2zA:
20.5		 2qakB-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QHC_B_AB1B9001_1
(PROTEASE RETROPEPSIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 11 ARG A   8
ASP A  25
ALA A  28
ASP A  30
ILE A  50
PRO A  81
ILE A  84
 None
 0.68A 2qhcA-5t2zA:
20.0		 2qhcA-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QHC_B_AB1B9001_1
(PROTEASE RETROPEPSIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 11 ASP A  25
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.43A 2qhcA-5t2zA:
20.0		 2qhcA-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QHC_B_AB1B9001_1
(PROTEASE RETROPEPSIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 1.47A 2qhcA-5t2zA:
20.0		 2qhcA-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QHC_B_AB1B9001_2
(PROTEASE RETROPEPSIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.51A 2qhcB-5t2zA:
20.0		 2qhcB-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_B_MK1B902_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
LEU A  23
ASP A  25
PRO A  81
ILE A  84
 None
 0.67A 2r5pA-5t2zA:
19.6		 2r5pA-5t2zA:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_B_MK1B902_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 LEU A  23
ASP A  25
ASP A  29
GLY A  49
ILE A  50
 None
 0.98A 2r5pA-5t2zA:
19.6		 2r5pA-5t2zA:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_B_MK1B902_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 12 LEU A  23
ASP A  25
ASP A  30
VAL A  32
ILE A  47
GLY A  49
PRO A  81
ILE A  84
 None
 0.55A 2r5pA-5t2zA:
19.6		 2r5pA-5t2zA:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_B_MK1B902_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 12 LEU A  23
ASP A  25
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.58A 2r5pA-5t2zA:
19.6		 2r5pA-5t2zA:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_B_MK1B902_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
ASP A  25
GLY A  27
PRO A  81
ILE A  84
 None
 0.67A 2r5pB-5t2zA:
19.8		 2r5pB-5t2zA:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_B_MK1B902_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  47
GLY A  49
PRO A  81
ILE A  84
 None
 0.53A 2r5pB-5t2zA:
19.8		 2r5pB-5t2zA:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_D_MK1D902_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
LEU A  23
ASP A  25
PRO A  81
ILE A  84
 None
 0.67A 2r5pC-5t2zA:
19.5		 2r5pC-5t2zA:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_D_MK1D902_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 LEU A  23
ASP A  25
ASP A  29
GLY A  49
ILE A  50
 None
 0.98A 2r5pC-5t2zA:
19.5		 2r5pC-5t2zA:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_D_MK1D902_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 12 LEU A  23
ASP A  25
ASP A  30
VAL A  32
ILE A  47
GLY A  49
PRO A  81
ILE A  84
 None
 0.55A 2r5pC-5t2zA:
19.5		 2r5pC-5t2zA:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_D_MK1D902_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 12 LEU A  23
ASP A  25
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.58A 2r5pC-5t2zA:
19.5		 2r5pC-5t2zA:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_D_MK1D902_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ARG A   8
ASP A  25
GLY A  27
ILE A  50
PRO A  81
ILE A  84
 None
 0.68A 2r5pD-5t2zA:
19.9		 2r5pD-5t2zA:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_D_MK1D902_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.55A 2r5pD-5t2zA:
19.9		 2r5pD-5t2zA:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5Q_B_1UNB900_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 ARG A   8
LEU A  23
ASP A  25
ILE A  50
PRO A  81
 None
 0.93A 2r5qA-5t2zA:
19.2		 2r5qA-5t2zA:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5Q_B_1UNB900_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 9 LEU A  23
ASP A  25
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.65A 2r5qA-5t2zA:
19.2		 2r5qA-5t2zA:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5Q_B_1UNB900_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.60A 2r5qB-5t2zA:
19.4		 2r5qB-5t2zA:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5Q_D_1UND900_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 ARG A   8
LEU A  23
ASP A  25
ILE A  50
PRO A  81
 None
 0.93A 2r5qC-5t2zA:
19.2		 2r5qC-5t2zA:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5Q_D_1UND900_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 9 LEU A  23
ASP A  25
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.65A 2r5qC-5t2zA:
19.2		 2r5qC-5t2zA:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5Q_D_1UND900_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.60A 2r5qD-5t2zA:
19.4		 2r5qD-5t2zA:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2RKF_A_AB1A501_1
(PROTEASE RETROPEPSIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ALA A  22
 None
 1.32A 2rkfA-5t2zA:
20.6		 2rkfA-5t2zA:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2RKF_A_AB1A501_1
(PROTEASE RETROPEPSIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.23A 2rkfA-5t2zA:
20.6		 2rkfA-5t2zA:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2RKF_A_AB1A501_1
(PROTEASE RETROPEPSIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.39A 2rkfA-5t2zA:
20.6		 2rkfA-5t2zA:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2RKG_B_AB1B501_2
(PROTEASE RETROPEPSIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.32A 2rkgB-5t2zA:
20.5		 2rkgB-5t2zA:
75.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Z54_A_AB1A200_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.41A 2z54A-5t2zA:
20.2		 2z54A-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYW_A_017A201_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.53A 3cywA-5t2zA:
20.1		 3cywA-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYW_A_017A201_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.44A 3cywA-5t2zA:
20.1		 3cywA-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYW_A_017A201_2
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		11 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.33A 3cywB-5t2zA:
20.3		 3cywB-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYX_A_ROCA201_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
PRO A  81
ILE A  84
 None
 0.58A 3cyxA-5t2zA:
20.0		 3cyxA-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYX_A_ROCA201_3
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  30
ILE A  47
GLY A  49
PRO A  81
ILE A  84
 None
 0.44A 3cyxB-5t2zA:
20.3		 3cyxB-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYX_A_ROCA201_4
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 4 LEU A  23
ASP A  29
VAL A  32
THR A  80
 None
 0.39A 3cyxB-5t2zA:
20.3		 3cyxB-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1X_A_ROCA201_2
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		11 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.53A 3d1xB-5t2zA:
20.2		 3d1xB-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1Y_A_ROCA201_2
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 9 ARG A   8
LEU A  23
ASP A  25
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.68A 3d1yB-5t2zA:
20.1		 3d1yB-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1Z_B_017B201_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.56A 3d1zA-5t2zA:
20.0		 3d1zA-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1Z_B_017B201_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
VAL A  32
ILE A  47
GLY A  49
ILE A  50
ILE A  84
 None
 0.42A 3d1zA-5t2zA:
20.0		 3d1zA-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1Z_B_017B201_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
VAL A  32
ILE A  47
GLY A  49
PRO A  81
ILE A  84
 None
 0.51A 3d1zA-5t2zA:
20.0		 3d1zA-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1Z_B_017B201_2
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.27A 3d1zB-5t2zA:
20.3		 3d1zB-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1Z_B_017B201_2
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		11 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.36A 3d1zB-5t2zA:
20.3		 3d1zB-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D20_A_017A201_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.35A 3d20A-5t2zA:
20.2		 3d20A-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D20_A_017A201_2
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.23A 3d20B-5t2zA:
20.2		 3d20B-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D20_A_017A201_2
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		11 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.32A 3d20B-5t2zA:
20.2		 3d20B-5t2zA:
81.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DL9_A_V2HA602_0
(CYTOCHROME P450 2R1)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ALA A  22
GLU A  65
VAL A  75
ILE A  15
THR A  31
 None
 1.00A 3dl9A-5t2zA:
undetectable		 3dl9A-5t2zA:
12.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EBZ_B_017B201_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  30
ILE A  50
PRO A  81
ILE A  84
 None
 0.61A 3ebzA-5t2zA:
19.0		 3ebzA-5t2zA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EBZ_B_017B201_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 11 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.52A 3ebzA-5t2zA:
19.0		 3ebzA-5t2zA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EBZ_B_017B201_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.27A 3ebzB-5t2zA:
19.2		 3ebzB-5t2zA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EBZ_B_017B201_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
 0.41A 3ebzB-5t2zA:
19.2		 3ebzB-5t2zA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKP_B_478B200_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
 1.38A 3ekpB-5t2zA:
20.0		 3ekpB-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKP_B_478B200_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.33A 3ekpB-5t2zA:
20.0		 3ekpB-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKP_C_478C200_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
 1.38A 3ekpC-5t2zA:
20.3		 3ekpC-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKP_C_478C200_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.31A 3ekpC-5t2zA:
20.3		 3ekpC-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKP_C_478C200_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 1.20A 3ekpD-5t2zA:
20.3		 3ekpD-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKP_C_478C200_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
ILE A  84
 None
 0.24A 3ekpD-5t2zA:
20.3		 3ekpD-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKQ_A_ROCA100_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ASP A  25
ALA A  28
ASP A  29
VAL A  48
GLY A  49
ILE A  50
 None
 1.39A 3ekqA-5t2zA:
19.8		 3ekqA-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKQ_A_ROCA100_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 ASP A  25
ALA A  28
ASP A  30
VAL A  48
GLY A  49
PRO A  81
ILE A  84
 None
 1.44A 3ekqA-5t2zA:
19.8		 3ekqA-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKQ_A_ROCA100_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		11 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
VAL A  48
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.55A 3ekqA-5t2zA:
19.8		 3ekqA-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKQ_A_ROCA100_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 9 ARG A   8
LEU A  23
ASP A  25
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.59A 3ekqB-5t2zA:
19.6		 3ekqB-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKT_B_017B200_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 9 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.24A 3ektA-5t2zA:
20.4		 3ektA-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKT_B_017B200_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
 None
 0.22A 3ektA-5t2zA:
20.4		 3ektA-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKT_B_017B200_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 9 ASP A  25
ALA A  28
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.22A 3ektB-5t2zA:
20.3		 3ektB-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKT_D_017D200_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		11 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.26A 3ektD-5t2zA:
20.1		 3ektD-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKV_A_478A200_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
ILE A  84
 None
 1.24A 3ekvA-5t2zA:
20.0		 3ekvA-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKV_A_478A200_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
ILE A  84
 None
 0.44A 3ekvA-5t2zA:
20.0		 3ekvA-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKV_A_478A200_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 9 ASP A  25
ALA A  28
ASP A  30
VAL A  32
ILE A  50
PRO A  81
ILE A  84
 None
 0.63A 3ekvB-5t2zA:
19.6		 3ekvB-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKV_A_478A200_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 9 ASP A  25
ALA A  28
VAL A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.42A 3ekvB-5t2zA:
19.6		 3ekvB-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKW_B_DR7B100_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 10 ARG A   8
ASP A  25
ALA A  28
ASP A  29
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.41A 3ekwA-5t2zA:
20.0		 3ekwA-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKW_B_DR7B100_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 10 ARG A   8
ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 1.41A 3ekwA-5t2zA:
20.0		 3ekwA-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKW_B_DR7B100_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  47
GLY A  49
ILE A  50
ILE A  84
 None
 0.44A 3ekwB-5t2zA:
19.6		 3ekwB-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKW_B_DR7B100_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  47
VAL A  48
GLY A  49
ILE A  84
 None
 0.56A 3ekwB-5t2zA:
19.6		 3ekwB-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKW_B_DR7B100_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.47A 3ekwB-5t2zA:
19.6		 3ekwB-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKW_B_DR7B100_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  47
VAL A  48
GLY A  49
PRO A  81
ILE A  84
 None
 0.51A 3ekwB-5t2zA:
19.6		 3ekwB-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKX_B_1UNB201_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
THR A  80
ILE A  84
 None
 0.59A 3ekxA-5t2zA:
19.7		 3ekxA-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKX_B_1UNB201_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
THR A  80
PRO A  81
ILE A  84
 None
 0.57A 3ekxA-5t2zA:
19.7		 3ekxA-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKX_B_1UNB201_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 11 ASP A  25
ALA A  28
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.54A 3ekxB-5t2zA:
20.1		 3ekxB-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKY_A_DR7A100_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 10 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.54A 3ekyA-5t2zA:
20.0		 3ekyA-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKY_A_DR7A100_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 9 ARG A   8
ASP A  25
ASP A  29
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.60A 3ekyB-5t2zA:
19.6		 3ekyB-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKY_A_DR7A100_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 9 ARG A   8
ASP A  25
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
 1.47A 3ekyB-5t2zA:
19.6		 3ekyB-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL0_A_1UNA201_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 8 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
THR A  80
PRO A  81
ILE A  84
 None
 0.30A 3el0A-5t2zA:
19.5		 3el0A-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL0_A_1UNA201_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 9 LEU A  23
ASP A  25
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.57A 3el0B-5t2zA:
19.7		 3el0B-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL1_A_DR7A100_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
 None
 1.49A 3el1A-5t2zA:
19.7		 3el1A-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL1_A_DR7A100_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 11 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
ILE A  84
 None
 0.43A 3el1A-5t2zA:
19.7		 3el1A-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL1_A_DR7A100_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 11 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
 0.52A 3el1A-5t2zA:
19.7		 3el1A-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL4_A_ROCA100_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
THR A  80
 None
 0.57A 3el4A-5t2zA:
19.6		 3el4A-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL4_A_ROCA100_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
THR A  80
PRO A  81
 None
 0.59A 3el4A-5t2zA:
19.6		 3el4A-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL4_A_ROCA100_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 9 ARG A   8
ASP A  25
ALA A  28
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
 None
 0.39A 3el4B-5t2zA:
20.0		 3el4B-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL5_B_1UNB201_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.29A 3el5A-5t2zA:
19.8		 3el5A-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL5_B_1UNB201_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
 None
 0.54A 3el5A-5t2zA:
19.8		 3el5A-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL5_B_1UNB201_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
THR A  80
PRO A  81
 None
 0.49A 3el5B-5t2zA:
19.7		 3el5B-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL9_A_DR7A100_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 8 ARG A   8
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
 None
 0.55A 3el9A-5t2zA:
19.4		 3el9A-5t2zA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL9_A_DR7A100_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 ARG A   8
ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
 None
 1.45A 3el9B-5t2zA:
20.0		 3el9B-5t2zA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL9_A_DR7A100_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 10 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  47
GLY A  49
ILE A  50
PRO A  81
 None
 0.42A 3el9B-5t2zA:
20.0		 3el9B-5t2zA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM3_B_478B200_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  30
VAL A  32
ILE A  47
GLY A  49
PRO A  81
ILE A  84
 None
 0.38A 3em3B-5t2zA:
19.9		 3em3B-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM4_A_DR7A100_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 11 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  47
GLY A  49
PRO A  81
ILE A  84
 None
 0.53A 3em4A-5t2zA:
19.7		 3em4A-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM4_A_DR7A100_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 9 ARG A   8
ASP A  25
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
 0.48A 3em4B-5t2zA:
20.0		 3em4B-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM4_V_DR7V100_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 11 ARG A   8
ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 1.42A 3em4U-5t2zA:
20.1		 3em4U-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM4_V_DR7V100_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 11 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  47
GLY A  49
PRO A  81
ILE A  84
 None
 0.41A 3em4U-5t2zA:
20.1		 3em4U-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM4_V_DR7V100_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 10 ARG A   8
ASP A  25
ASP A  29
ILE A  47
GLY A  49
PRO A  81
ILE A  84
 None
 0.51A 3em4V-5t2zA:
19.8		 3em4V-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3GGU_B_017B201_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
 None
 1.16A 3gguA-5t2zA:
20.4		 3gguA-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3GGU_B_017B201_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
 None
 0.23A 3gguA-5t2zA:
20.4		 3gguA-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3GGU_B_017B201_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 9 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.21A 3gguB-5t2zA:
20.4		 3gguB-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3GGU_B_017B201_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
 0.20A 3gguB-5t2zA:
20.4		 3gguB-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3JVY_B_017B401_1
(GAG-POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.48A 3jvyA-5t2zA:
20.0		 3jvyA-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3JVY_B_017B401_1
(GAG-POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.38A 3jvyA-5t2zA:
20.0		 3jvyA-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3JVY_B_017B401_2
(GAG-POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
 None
 0.61A 3jvyB-5t2zA:
20.1		 3jvyB-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3JVY_B_017B401_2
(GAG-POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  47
GLY A  49
ILE A  50
ILE A  84
 None
 0.31A 3jvyB-5t2zA:
20.1		 3jvyB-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K4V_D_ROCD201_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.48A 3k4vC-5t2zA:
19.8		 3k4vC-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K4V_D_ROCD201_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		11 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.56A 3k4vC-5t2zA:
19.8		 3k4vC-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K4V_D_ROCD201_3
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.32A 3k4vD-5t2zA:
19.7		 3k4vD-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K4V_D_ROCD201_3
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
ILE A  84
 None
 0.46A 3k4vD-5t2zA:
19.7		 3k4vD-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K4V_D_ROCD201_3
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
PRO A  81
ILE A  84
 None
 0.50A 3k4vD-5t2zA:
19.7		 3k4vD-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K4V_D_ROCD201_4
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		3 / 3 ARG A   8
VAL A  32
THR A  80
 None
 0.25A 3k4vD-5t2zA:
19.7		 3k4vD-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZS_A_017A200_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
 None
 1.39A 3lzsA-5t2zA:
21.0		 3lzsA-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZS_A_017A200_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		11 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.26A 3lzsA-5t2zA:
21.0		 3lzsA-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZS_A_017A200_2
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		11 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.26A 3lzsB-5t2zA:
21.0		 3lzsB-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZU_A_017A200_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
 None
 1.38A 3lzuA-5t2zA:
21.1		 3lzuA-5t2zA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZU_A_017A200_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		11 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.28A 3lzuA-5t2zA:
21.1		 3lzuA-5t2zA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZV_A_017A200_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  47
GLY A  49
ILE A  50
 None
 0.41A 3lzvA-5t2zA:
19.4		 3lzvA-5t2zA:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZV_A_017A200_2
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 11 ASP A  25
ALA A  28
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.49A 3lzvB-5t2zA:
19.1		 3lzvB-5t2zA:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MWS_B_017B201_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
 None
 1.35A 3mwsA-5t2zA:
19.5		 3mwsA-5t2zA:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MWS_B_017B201_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		11 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.45A 3mwsA-5t2zA:
19.5		 3mwsA-5t2zA:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MWS_B_017B201_2
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.33A 3mwsB-5t2zA:
19.3		 3mwsB-5t2zA:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3N3I_A_ROCA201_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.21A 3n3iA-5t2zA:
14.2		 3n3iA-5t2zA:
40.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3N3I_A_ROCA201_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 None
 0.39A 3n3iA-5t2zA:
14.2		 3n3iA-5t2zA:
40.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3N3I_A_ROCA201_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 0.37A 3n3iA-5t2zA:
14.2		 3n3iA-5t2zA:
40.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_A_ROCA101_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		3 / 3 ARG A   8
VAL A  32
THR A  80
 None
 0.53A 3ndtA-5t2zA:
19.6		 3ndtA-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_D_ROCD100_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.48A 3ndtC-5t2zA:
19.8		 3ndtC-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_D_ROCD100_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
ILE A  47
GLY A  49
ILE A  50
ILE A  84
 None
 0.46A 3ndtC-5t2zA:
19.8		 3ndtC-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_D_ROCD100_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
ILE A  47
GLY A  49
PRO A  81
ILE A  84
 None
 0.56A 3ndtC-5t2zA:
19.8		 3ndtC-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_D_ROCD100_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.34A 3ndtD-5t2zA:
19.8		 3ndtD-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_D_ROCD100_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
ILE A  84
 None
 0.40A 3ndtD-5t2zA:
19.8		 3ndtD-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_D_ROCD100_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
PRO A  81
ILE A  84
 None
 0.55A 3ndtD-5t2zA:
19.8		 3ndtD-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_A_ROCA101_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.31A 3nduA-5t2zA:
19.7		 3nduA-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_A_ROCA101_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		11 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.55A 3nduA-5t2zA:
19.7		 3nduA-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_A_ROCA101_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.34A 3nduB-5t2zA:
20.1		 3nduB-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_A_ROCA101_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
ILE A  84
 None
 0.47A 3nduB-5t2zA:
20.1		 3nduB-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_A_ROCA101_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
PRO A  81
ILE A  84
 None
 0.45A 3nduB-5t2zA:
20.1		 3nduB-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_D_ROCD100_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ARG A   8
LEU A  23
ASP A  25
ASP A  29
GLY A  49
ILE A  50
 None
 1.32A 3nduC-5t2zA:
19.9		 3nduC-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_D_ROCD100_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		11 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.54A 3nduC-5t2zA:
19.9		 3nduC-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_D_ROCD100_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.31A 3nduD-5t2zA:
19.4		 3nduD-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_D_ROCD100_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
ILE A  84
 None
 0.51A 3nduD-5t2zA:
19.4		 3nduD-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_D_ROCD100_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
PRO A  81
ILE A  84
 None
 0.50A 3nduD-5t2zA:
19.4		 3nduD-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDW_A_RITA100_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
ILE A  84
 None
 0.38A 3ndwA-5t2zA:
20.0		 3ndwA-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDW_A_RITA100_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
PRO A  81
ILE A  84
 None
 0.66A 3ndwA-5t2zA:
20.0		 3ndwA-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDW_A_RITA100_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 9 ARG A   8
ASP A  25
ALA A  28
ASP A  29
ILE A  47
GLY A  49
ILE A  50
ILE A  84
 None
 0.48A 3ndwB-5t2zA:
19.6		 3ndwB-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDX_A_RITA100_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
ILE A  84
 None
 0.42A 3ndxA-5t2zA:
20.0		 3ndxA-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDX_A_RITA100_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
PRO A  81
ILE A  84
 None
 0.65A 3ndxA-5t2zA:
20.0		 3ndxA-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDX_A_RITA100_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 11 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
ILE A  84
 None
 0.54A 3ndxB-5t2zA:
19.8		 3ndxB-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU3_B_478B401_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 None
 0.40A 3nu3A-5t2zA:
20.1		 3nu3A-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU3_B_478B401_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.53A 3nu3A-5t2zA:
20.1		 3nu3A-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU3_B_478B401_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.26A 3nu3B-5t2zA:
19.8		 3nu3B-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU3_B_478B401_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
GLY A  49
ILE A  50
ILE A  84
 None
 0.50A 3nu3B-5t2zA:
19.8		 3nu3B-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU4_B_478B401_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 ASP A  25
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 None
 0.43A 3nu4A-5t2zA:
20.1		 3nu4A-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU4_B_478B401_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 9 ASP A  25
ALA A  28
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.49A 3nu4A-5t2zA:
20.1		 3nu4A-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU4_B_478B401_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 9 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.26A 3nu4B-5t2zA:
19.7		 3nu4B-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU4_B_478B401_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
 0.47A 3nu4B-5t2zA:
19.7		 3nu4B-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU5_B_478B401_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  84
 None
 0.46A 3nu5B-5t2zA:
20.1		 3nu5B-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU6_B_478B401_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 10 ASP A  25
ALA A  28
ASP A  30
VAL A  32
ILE A  47
ILE A  50
PRO A  81
ILE A  84
 None
 0.74A 3nu6A-5t2zA:
19.9		 3nu6A-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU6_B_478B401_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 10 ASP A  25
ALA A  28
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.65A 3nu6A-5t2zA:
19.9		 3nu6A-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU6_B_478B401_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.30A 3nu6B-5t2zA:
20.1		 3nu6B-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU6_B_478B401_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
GLY A  49
ILE A  50
ILE A  84
 None
 0.37A 3nu6B-5t2zA:
20.1		 3nu6B-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU9_A_478A401_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 8 ASP A  25
ALA A  28
ASP A  30
VAL A  32
PRO A  81
 None
 0.56A 3nu9A-5t2zA:
19.9		 3nu9A-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU9_A_478A401_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 8 ASP A  25
ALA A  28
VAL A  32
GLY A  49
ILE A  50
PRO A  81
 None
 0.43A 3nu9A-5t2zA:
19.9		 3nu9A-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU9_A_478A401_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 10 LEU A  23
ASP A  25
ASP A  29
GLY A  49
ILE A  50
 None
 1.01A 3nu9B-5t2zA:
20.2		 3nu9B-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU9_A_478A401_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
GLY A  49
ILE A  50
 None
 0.36A 3nu9B-5t2zA:
20.2		 3nu9B-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NUJ_B_478B401_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 10 ASP A  25
ALA A  28
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.69A 3nujA-5t2zA:
20.1		 3nujA-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NUJ_B_478B401_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 9 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.25A 3nujB-5t2zA:
19.9		 3nujB-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NUJ_B_478B401_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
GLY A  49
ILE A  50
ILE A  84
 None
 0.41A 3nujB-5t2zA:
19.9		 3nujB-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NUO_B_478B478_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 9 ASP A  25
ALA A  28
ASP A  30
ILE A  47
PRO A  81
ILE A  84
 None
 0.60A 3nuoA-5t2zA:
20.1		 3nuoA-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NUO_B_478B478_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 9 ASP A  25
ALA A  28
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.55A 3nuoA-5t2zA:
20.1		 3nuoA-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NUO_B_478B478_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 9 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.26A 3nuoB-5t2zA:
19.8		 3nuoB-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NUO_B_478B478_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
GLY A  49
ILE A  50
ILE A  84
 None
 0.45A 3nuoB-5t2zA:
19.8		 3nuoB-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OGP_A_017A200_1
(FIV PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 0.60A 3ogpA-5t2zA:
15.3		 3ogpA-5t2zA:
31.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OGP_A_017A200_2
(FIV PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
VAL A  32
GLY A  49
ILE A  50
 None
 0.50A 3ogpB-5t2zA:
15.3		 3ogpB-5t2zA:
31.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OGP_B_017B200_1
(FIV PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 10 LEU A  23
ASP A  25
ALA A  28
GLY A  49
ILE A  50
 None
 0.50A 3ogpA-5t2zA:
15.3		 3ogpA-5t2zA:
31.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OGP_B_017B200_2
(FIV PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 0.40A 3ogpB-5t2zA:
15.3		 3ogpB-5t2zA:
31.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OGQ_A_AB1A200_1
(FIV PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
VAL A  32
GLY A  49
ILE A  50
 None
 0.60A 3ogqA-5t2zA:
15.2		 3ogqA-5t2zA:
31.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OGQ_A_AB1A200_2
(FIV PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  49
ILE A  50
 None
 0.56A 3ogqB-5t2zA:
15.2		 3ogqB-5t2zA:
31.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OGQ_A_AB1A200_2
(FIV PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 0.39A 3ogqB-5t2zA:
15.2		 3ogqB-5t2zA:
31.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXC_A_ROCA401_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
ILE A  84
 None
 0.39A 3oxcA-5t2zA:
19.2		 3oxcA-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXC_A_ROCA401_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  47
PRO A  81
ILE A  84
 None
 0.48A 3oxcA-5t2zA:
19.2		 3oxcA-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXC_A_ROCA401_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		3 / 3 ARG A   8
LEU A  23
THR A  80
 None
 0.40A 3oxcA-5t2zA:
19.2		 3oxcA-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXC_A_ROCA401_3
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ARG A   8
LEU A  23
ASP A  25
ASP A  29
GLY A  49
ILE A  50
 None
 1.35A 3oxcB-5t2zA:
19.3		 3oxcB-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXC_A_ROCA401_3
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
ILE A  47
GLY A  49
ILE A  50
ILE A  84
 None
 0.57A 3oxcB-5t2zA:
19.3		 3oxcB-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXC_A_ROCA401_3
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
ILE A  47
GLY A  49
PRO A  81
ILE A  84
 None
 0.52A 3oxcB-5t2zA:
19.3		 3oxcB-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXV_A_478A200_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 6 TRP A  42
PRO A  44
ARG A  57
GLY A  78
 None
 0.29A 3oxvA-5t2zA:
20.0		 3oxvA-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXV_B_478B200_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
 0.39A 3oxvA-5t2zA:
20.0		 3oxvA-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXV_B_478B200_2
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 10 ASP A  25
ALA A  28
ASP A  30
VAL A  32
ILE A  47
GLY A  49
PRO A  81
ILE A  84
 None
 0.66A 3oxvB-5t2zA:
20.0		 3oxvB-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXV_C_478C200_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
GLY A  49
ILE A  84
 None
 0.41A 3oxvC-5t2zA:
20.0		 3oxvC-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXV_C_478C200_2
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 11 ASP A  25
ALA A  28
ASP A  30
VAL A  32
ILE A  47
GLY A  49
PRO A  81
ILE A  84
 None
 0.39A 3oxvD-5t2zA:
19.9		 3oxvD-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXW_B_017B200_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
 None
 0.27A 3oxwA-5t2zA:
20.1		 3oxwA-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXW_B_017B200_2
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
 1.48A 3oxwB-5t2zA:
20.1		 3oxwB-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXW_B_017B200_2
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  30
VAL A  32
ILE A  47
GLY A  49
PRO A  81
ILE A  84
 None
 0.35A 3oxwB-5t2zA:
20.1		 3oxwB-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXW_D_017D200_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
 None
 0.19A 3oxwC-5t2zA:
20.0		 3oxwC-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXW_D_017D200_2
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 1.19A 3oxwD-5t2zA:
20.2		 3oxwD-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXW_D_017D200_2
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  30
VAL A  32
GLY A  49
PRO A  81
ILE A  84
 None
 0.36A 3oxwD-5t2zA:
20.2		 3oxwD-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXX_A_DR7A100_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
 None
 1.47A 3oxxA-5t2zA:
19.9		 3oxxA-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXX_A_DR7A100_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		11 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  47
GLY A  49
PRO A  81
ILE A  84
 None
 0.36A 3oxxA-5t2zA:
19.9		 3oxxA-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXX_A_DR7A100_2
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ILE A  47
GLY A  49
PRO A  81
ILE A  84
 None
 0.37A 3oxxB-5t2zA:
20.0		 3oxxB-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXX_A_DR7A100_2
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
 None
 1.47A 3oxxB-5t2zA:
20.0		 3oxxB-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXX_C_DR7C100_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  47
GLY A  49
PRO A  81
ILE A  84
 None
 0.46A 3oxxC-5t2zA:
19.8		 3oxxC-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OY4_B_017B200_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 ARG A   8
LEU A  23
ASP A  25
ASP A  29
PRO A  81
ILE A  84
 None
 1.34A 3oy4A-5t2zA:
19.3		 3oy4A-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OY4_B_017B200_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 ARG A   8
LEU A  23
ASP A  25
ASP A  30
PRO A  81
ILE A  84
 None
 0.82A 3oy4A-5t2zA:
19.3		 3oy4A-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OY4_B_017B200_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 LEU A  23
ASP A  25
ALA A  28
ASP A  29
PRO A  81
ILE A  84
 None
 1.38A 3oy4A-5t2zA:
19.3		 3oy4A-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OY4_B_017B200_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 11 LEU A  23
ASP A  25
ALA A  28
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.61A 3oy4A-5t2zA:
19.3		 3oy4A-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OY4_B_017B200_2
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.21A 3oy4B-5t2zA:
19.8		 3oy4B-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OY4_B_017B200_2
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
 None
 0.44A 3oy4B-5t2zA:
19.8		 3oy4B-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWM_B_017B402_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.37A 3pwmA-5t2zA:
20.0		 3pwmA-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWM_B_017B402_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ASP A  29
VAL A  32
GLY A  49
ILE A  50
PRO A  81
 None
 0.52A 3pwmB-5t2zA:
20.2		 3pwmB-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWM_B_017B402_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.26A 3pwmB-5t2zA:
20.2		 3pwmB-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWM_B_017B402_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
ILE A  84
 None
 0.32A 3pwmB-5t2zA:
20.2		 3pwmB-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWR_A_ROCA401_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.35A 3pwrA-5t2zA:
19.8		 3pwrA-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWR_A_ROCA401_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
ILE A  84
 None
 0.47A 3pwrA-5t2zA:
19.8		 3pwrA-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWR_A_ROCA401_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
PRO A  81
ILE A  84
 None
 0.58A 3pwrA-5t2zA:
19.8		 3pwrA-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWR_A_ROCA401_3
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.49A 3pwrB-5t2zA:
20.0		 3pwrB-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWR_A_ROCA401_3
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		11 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
ILE A  84
 None
 0.41A 3pwrB-5t2zA:
20.0		 3pwrB-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S43_A_478A401_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 ASP A  25
ALA A  28
GLY A  49
ILE A  50
ILE A  84
 None
 0.44A 3s43A-5t2zA:
20.0		 3s43A-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S43_A_478A401_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.28A 3s43B-5t2zA:
19.8		 3s43B-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S43_A_478A401_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
 0.48A 3s43B-5t2zA:
19.8		 3s43B-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S45_B_478B201_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 9 ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.41A 3s45A-5t2zA:
19.0		 3s45A-5t2zA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S45_B_478B201_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
 0.48A 3s45B-5t2zA:
19.1		 3s45B-5t2zA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S53_A_017A201_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
 0.42A 3s53A-5t2zA:
19.6		 3s53A-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S53_A_017A201_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 11 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.55A 3s53B-5t2zA:
20.1		 3s53B-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S53_B_017B203_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 5 TRP A  42
PRO A  44
ARG A  57
GLY A  78
 None
 0.22A 3s53B-5t2zA:
20.1		 3s53B-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S53_B_017B203_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 5 TRP A  42
PRO A  44
LYS A  55
GLY A  78
 None
 1.15A 3s53B-5t2zA:
20.1		 3s53B-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S56_A_ROCA201_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
THR A  80
PRO A  81
 None
 0.61A 3s56A-5t2zA:
19.7		 3s56A-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S56_A_ROCA201_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 9 ARG A   8
LEU A  23
ASP A  25
ASP A  29
GLY A  49
ILE A  50
 None
 1.27A 3s56B-5t2zA:
19.6		 3s56B-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S56_A_ROCA201_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 9 ARG A   8
LEU A  23
ASP A  25
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.58A 3s56B-5t2zA:
19.6		 3s56B-5t2zA:
78.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SM2_A_478A126_2
(GAG-PRO-POL
POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 ASP A  25
ALA A  28
VAL A  32
GLY A  49
LEU A  76
 None
 0.74A 3sm2B-5t2zA:
11.0		 3sm2B-5t2zA:
29.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SM2_A_478A126_2
(GAG-PRO-POL
POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 ASP A  25
ALA A  28
VAL A  32
LEU A  76
PRO A  81
 None
 0.74A 3sm2B-5t2zA:
11.0		 3sm2B-5t2zA:
29.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SO9_A_017A100_2
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 LEU A  23
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
 None
 0.90A 3so9B-5t2zA:
19.8		 3so9B-5t2zA:
84.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SPK_A_TPVA100_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 11 ARG A   8
LEU A  23
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
 None
 0.55A 3spkA-5t2zA:
21.3		 3spkA-5t2zA:
84.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SPK_A_TPVA100_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 ARG A   8
LEU A  23
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.49A 3spkA-5t2zA:
21.3		 3spkA-5t2zA:
84.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SPK_A_TPVA100_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 11 LEU A  23
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
PRO A  81
 None
 0.61A 3spkA-5t2zA:
21.3		 3spkA-5t2zA:
84.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SPK_B_TPVB100_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 9 ARG A   8
LEU A  23
ALA A  28
VAL A  32
GLY A  49
ILE A  50
 None
 0.58A 3spkA-5t2zA:
21.3		 3spkA-5t2zA:
84.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SPK_B_TPVB100_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 9 LEU A  23
ALA A  28
VAL A  32
GLY A  49
ILE A  50
PRO A  81
 None
 0.64A 3spkA-5t2zA:
21.3		 3spkA-5t2zA:
84.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SPK_B_TPVB100_2
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 ARG A   8
LEU A  23
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
 None
 0.59A 3spkB-5t2zA:
21.4		 3spkB-5t2zA:
84.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3T3C_A_017A201_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 7 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  50
 None
 0.42A 3t3cA-5t2zA:
19.1		 3t3cA-5t2zA:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3T3C_A_017A201_2
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 10 ASP A  25
ALA A  28
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
 None
 0.62A 3t3cB-5t2zA:
19.4		 3t3cB-5t2zA:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_B_ROCB801_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.33A 3tkgA-5t2zA:
19.8		 3tkgA-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_B_ROCB801_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		11 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.50A 3tkgA-5t2zA:
19.8		 3tkgA-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_B_ROCB801_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.47A 3tkgB-5t2zA:
19.8		 3tkgB-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_B_ROCB801_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		11 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.47A 3tkgB-5t2zA:
19.8		 3tkgB-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_C_ROCC901_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
THR A  80
PRO A  81
ILE A  84
 None
 0.42A 3tkgC-5t2zA:
18.9		 3tkgC-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_C_ROCC901_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  47
GLY A  49
ILE A  50
THR A  80
PRO A  81
ILE A  84
 None
 0.50A 3tkgC-5t2zA:
18.9		 3tkgC-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_C_ROCC901_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
 None
 0.36A 3tkgD-5t2zA:
19.8		 3tkgD-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_C_ROCC901_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 ARG A   8
LEU A  23
GLY A  27
ALA A  28
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
ILE A  84
 None
 0.43A 3tkgD-5t2zA:
19.8		 3tkgD-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_C_ROCC901_3
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		3 / 3 ASP A  29
THR A  80
PRO A  81
 None
 0.16A 3tkgD-5t2zA:
19.8		 3tkgD-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKW_B_017B401_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
ILE A  84
 None
 0.25A 3tkwA-5t2zA:
20.3		 3tkwA-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TTP_A_017A201_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.21A 3ttpA-5t2zA:
20.2		 3ttpA-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TTP_A_017A201_2
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.20A 3ttpB-5t2zA:
20.1		 3ttpB-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3U7S_A_017A201_1
(POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 9 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.23A 3u7sA-5t2zA:
19.8		 3u7sA-5t2zA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3U7S_A_017A201_1
(POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
 0.35A 3u7sA-5t2zA:
19.8		 3u7sA-5t2zA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3U7S_A_017A201_2
(POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 9 ARG A   8
ASP A  25
ALA A  28
ASP A  30
ILE A  47
GLY A  49
ILE A  50
PRO A  81
 None
 0.46A 3u7sB-5t2zA:
20.0		 3u7sB-5t2zA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3U7S_A_017A202_1
(POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 9 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.23A 3u7sA-5t2zA:
19.8		 3u7sA-5t2zA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3U7S_A_017A202_1
(POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 9 LEU A  23
ASP A  25
ALA A  28
ASP A  30
ILE A  47
GLY A  49
ILE A  50
PRO A  81
 None
 0.48A 3u7sA-5t2zA:
19.8		 3u7sA-5t2zA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3U7S_A_017A202_2
(POL POLYPROTEIN)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
 0.14A 3u7sB-5t2zA:
20.0		 3u7sB-5t2zA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UCB_A_017A201_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
 None
 0.34A 3ucbA-5t2zA:
19.5		 3ucbA-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UCB_A_017A201_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
 None
 0.41A 3ucbB-5t2zA:
20.7		 3ucbB-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UCB_B_017B202_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 7 TRP A  42
PRO A  44
ARG A  57
GLY A  78
PRO A  79
 None
 0.27A 3ucbB-5t2zA:
20.7		 3ucbB-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UCB_B_017B202_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 7 TRP A  42
PRO A  44
LYS A  55
ARG A  57
 None
 0.65A 3ucbB-5t2zA:
20.7		 3ucbB-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UFN_A_ROCA401_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
THR A  80
PRO A  81
 None
 0.45A 3ufnA-5t2zA:
19.7		 3ufnA-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UFN_A_ROCA401_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 ASP A  25
GLY A  27
ALA A  28
GLY A  49
THR A  80
 None
 0.75A 3ufnA-5t2zA:
19.7		 3ufnA-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UFN_A_ROCA401_2
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 7 ARG A   8
ASP A  25
GLY A  49
ILE A  50
 None
 0.37A 3ufnB-5t2zA:
20.3		 3ufnB-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3WSJ_A_MK1A201_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 9 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ILE A  84
 None
 0.63A 3wsjA-5t2zA:
12.3		 3wsjA-5t2zA:
33.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3WSJ_A_MK1A201_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 9 LEU A  23
ASP A  25
ALA A  28
ASP A  29
VAL A  32
LEU A  76
ILE A  84
 None
 0.85A 3wsjA-5t2zA:
12.3		 3wsjA-5t2zA:
33.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQB_B_017B101_2
(ASPARTYL PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.18A 4dqbB-5t2zA:
20.0		 4dqbB-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQB_B_017B101_2
(ASPARTYL PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
 None
 0.44A 4dqbB-5t2zA:
20.0		 4dqbB-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQC_A_017A101_1
(ASPARTYL PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 10 ASP A  25
ALA A  28
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.40A 4dqcA-5t2zA:
19.5		 4dqcA-5t2zA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQC_A_017A101_2
(ASPARTYL PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 9 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.18A 4dqcB-5t2zA:
20.3		 4dqcB-5t2zA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQC_A_017A101_2
(ASPARTYL PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
 None
 0.32A 4dqcB-5t2zA:
20.3		 4dqcB-5t2zA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQE_B_017B101_1
(ASPARTYL PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ILE A  50
PRO A  81
ILE A  84
 None
 0.71A 4dqeA-5t2zA:
19.8		 4dqeA-5t2zA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQE_B_017B101_1
(ASPARTYL PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 11 LEU A  23
ASP A  25
ALA A  28
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.40A 4dqeA-5t2zA:
19.8		 4dqeA-5t2zA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQE_B_017B101_2
(ASPARTYL PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.18A 4dqeB-5t2zA:
20.2		 4dqeB-5t2zA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQE_B_017B101_2
(ASPARTYL PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
 None
 0.40A 4dqeB-5t2zA:
20.2		 4dqeB-5t2zA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQH_B_017B101_1
(WILD-TYPE HIV-1
PROTEASE DIMER)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 ARG A   8
LEU A  23
ASP A  25
ILE A  50
PRO A  81
ILE A  84
 None
 0.82A 4dqhA-5t2zA:
19.8		 4dqhA-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQH_B_017B101_1
(WILD-TYPE HIV-1
PROTEASE DIMER)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 11 LEU A  23
ASP A  25
ALA A  28
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.41A 4dqhA-5t2zA:
19.8		 4dqhA-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQH_B_017B101_2
(WILD-TYPE HIV-1
PROTEASE DIMER)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.18A 4dqhB-5t2zA:
20.2		 4dqhB-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQH_B_017B101_2
(WILD-TYPE HIV-1
PROTEASE DIMER)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
 None
 0.42A 4dqhB-5t2zA:
20.2		 4dqhB-5t2zA:
77.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4G0V_A_MIXA1301_1
(DNA TOPOISOMERASE
2-BETA)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 7 ARG A  87
GLY A  86
ILE A  84
GLN A  92
 None
 0.90A 4g0vA-5t2zA:
undetectable		 4g0vA-5t2zA:
9.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4HLA_A_017A200_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 1.36A 4hlaA-5t2zA:
20.5		 4hlaA-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4HLA_A_017A200_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.33A 4hlaA-5t2zA:
20.5		 4hlaA-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4HLA_A_017A200_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
 None
 1.43A 4hlaB-5t2zA:
20.4		 4hlaB-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4HLA_A_017A200_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.35A 4hlaB-5t2zA:
20.4		 4hlaB-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4J5J_B_478B401_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 10 ASP A  25
ALA A  28
GLY A  49
ILE A  50
PRO A  81
 None
 0.53A 4j5jB-5t2zA:
19.8		 4j5jB-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4J5J_B_478B402_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 5 TRP A  42
PRO A  44
ARG A  57
PRO A  79
 None
 0.30A 4j5jB-5t2zA:
19.8		 4j5jB-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4J5J_B_478B402_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 5 TRP A  42
PRO A  44
LYS A  55
ARG A  57
 None
 0.68A 4j5jB-5t2zA:
19.8		 4j5jB-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JEC_B_478B401_2
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.48A 4jecB-5t2zA:
20.0		 4jecB-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JEC_B_478B401_2
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.45A 4jecB-5t2zA:
20.0		 4jecB-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4L1A_A_AB1A101_1
(MDR769 HIV-1
PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 11 ARG A   8
GLY A  27
ALA A  28
ASP A  29
ASP A  30
THR A  80
PRO A  81
 None
 0.60A 4l1aA-5t2zA:
18.5		 4l1aA-5t2zA:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A201_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
ILE A  84
 None
 1.20A 4ll3B-5t2zA:
20.6		 4ll3B-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A201_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
ILE A  84
 None
 0.22A 4ll3B-5t2zA:
20.6		 4ll3B-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A202_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
ILE A  84
 None
 1.16A 4ll3A-5t2zA:
20.5		 4ll3A-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A202_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
ILE A  84
 None
 0.23A 4ll3A-5t2zA:
20.5		 4ll3A-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A202_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 9 ARG A   8
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 1.49A 4ll3B-5t2zA:
20.6		 4ll3B-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A202_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 9 ARG A   8
ASP A  25
ALA A  28
ASP A  30
VAL A  32
GLY A  49
PRO A  81
ILE A  84
 None
 0.47A 4ll3B-5t2zA:
20.6		 4ll3B-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJT_B_017B101_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 11 LEU A  23
ASP A  25
ALA A  28
ASP A  30
VAL A  32
ILE A  47
PRO A  81
ILE A  84
 None
 0.65A 4njtA-5t2zA:
19.9		 4njtA-5t2zA:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJT_B_017B101_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 11 LEU A  23
ASP A  25
ALA A  28
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.48A 4njtA-5t2zA:
19.9		 4njtA-5t2zA:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJT_B_017B101_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.18A 4njtB-5t2zA:
20.1		 4njtB-5t2zA:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJT_B_017B101_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
 None
 0.36A 4njtB-5t2zA:
20.1		 4njtB-5t2zA:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJT_D_017D101_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 11 LEU A  23
ASP A  25
ALA A  28
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.62A 4njtC-5t2zA:
19.9		 4njtC-5t2zA:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJT_D_017D101_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 LEU A  23
ASP A  25
ALA A  28
ASP A  29
ILE A  50
 None
 1.18A 4njtD-5t2zA:
20.1		 4njtD-5t2zA:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJT_D_017D101_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  50
 None
 0.39A 4njtD-5t2zA:
20.1		 4njtD-5t2zA:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJU_A_TPVA500_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		11 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
 None
 0.50A 4njuA-5t2zA:
20.0		 4njuA-5t2zA:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJU_A_TPVA500_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
 None
 1.44A 4njuA-5t2zA:
20.0		 4njuA-5t2zA:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJU_A_TPVA500_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 ARG A   8
ALA A  28
VAL A  32
GLY A  49
ILE A  50
PRO A  81
 None
 0.83A 4njuB-5t2zA:
20.0		 4njuB-5t2zA:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJU_A_TPVA500_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 10 ARG A   8
LEU A  23
ASP A  25
ALA A  28
VAL A  32
GLY A  49
ILE A  50
ILE A  84
 None
 0.59A 4njuB-5t2zA:
20.0		 4njuB-5t2zA:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJU_C_TPVC500_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		11 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
 None
 0.52A 4njuC-5t2zA:
20.0		 4njuC-5t2zA:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJU_C_TPVC500_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
 None
 1.43A 4njuC-5t2zA:
20.0		 4njuC-5t2zA:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJU_C_TPVC500_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 ARG A   8
ALA A  28
VAL A  32
GLY A  49
ILE A  50
PRO A  81
 None
 0.84A 4njuD-5t2zA:
20.0		 4njuD-5t2zA:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJU_C_TPVC500_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 10 ARG A   8
LEU A  23
ASP A  25
ALA A  28
VAL A  32
GLY A  49
ILE A  50
ILE A  84
 None
 0.59A 4njuD-5t2zA:
20.0		 4njuD-5t2zA:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_A_RITA500_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		11 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.51A 4njvA-5t2zA:
19.9		 4njvA-5t2zA:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_A_RITA500_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 ARG A   8
ASP A  25
ASP A  29
GLY A  49
ILE A  50
PRO A  81
 None
 1.39A 4njvB-5t2zA:
20.0		 4njvB-5t2zA:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_A_RITA500_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 11 ARG A   8
ASP A  25
GLY A  27
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.50A 4njvB-5t2zA:
20.0		 4njvB-5t2zA:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_D_RITD500_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 ARG A   8
ASP A  25
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
 1.43A 4njvC-5t2zA:
19.8		 4njvC-5t2zA:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_D_RITD500_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 11 ARG A   8
ASP A  25
GLY A  27
ASP A  29
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.47A 4njvC-5t2zA:
19.8		 4njvC-5t2zA:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_D_RITD500_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
ILE A  84
 None
 0.41A 4njvD-5t2zA:
20.0		 4njvD-5t2zA:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_D_RITD500_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
VAL A  32
ILE A  47
GLY A  49
PRO A  81
ILE A  84
 None
 0.56A 4njvD-5t2zA:
20.0		 4njvD-5t2zA:
85.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OLM_A_198A1001_2
(ANDROGEN RECEPTOR)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 6 ASN A  83
ILE A  64
ILE A  15
VAL A  62
 None
 0.96A 4olmA-5t2zA:
undetectable		 4olmA-5t2zA:
14.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1W_A_017A104_1
(ASPARTYL PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 9 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.22A 4q1wA-5t2zA:
19.9		 4q1wA-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1W_A_017A104_1
(ASPARTYL PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
 0.44A 4q1wA-5t2zA:
19.9		 4q1wA-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1W_A_017A104_2
(ASPARTYL PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 ASP A  25
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.66A 4q1wB-5t2zA:
19.3		 4q1wB-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1W_A_017A104_2
(ASPARTYL PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 10 ASP A  25
ALA A  28
VAL A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.51A 4q1wB-5t2zA:
19.3		 4q1wB-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1Y_A_017A106_1
(ASPARTYL PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.24A 4q1yA-5t2zA:
20.0		 4q1yA-5t2zA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1Y_A_017A106_1
(ASPARTYL PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
 0.45A 4q1yA-5t2zA:
20.0		 4q1yA-5t2zA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1Y_A_017A106_2
(ASPARTYL PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 None
 0.50A 4q1yB-5t2zA:
19.4		 4q1yB-5t2zA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1Y_A_017A106_2
(ASPARTYL PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 12 LEU A  23
ASP A  25
ALA A  28
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.46A 4q1yB-5t2zA:
19.4		 4q1yB-5t2zA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q5M_A_ROCA1101_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ASP A  29
ILE A  47
ILE A  50
THR A  80
PRO A  81
 None
 0.53A 4q5mA-5t2zA:
17.5		 4q5mA-5t2zA:
40.39
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q5M_A_ROCA1101_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
ALA A  28
VAL A  32
GLY A  49
ILE A  84
 None
 0.39A 4q5mA-5t2zA:
17.5		 4q5mA-5t2zA:
40.39
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q5M_A_ROCA1101_2
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.62A 4q5mA-5t2zA:
17.5		 4q5mA-5t2zA:
40.39
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QGI_A_ROCA101_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
THR A  80
 None
 0.67A 4qgiA-5t2zA:
20.0		 4qgiA-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RVJ_B_478B101_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 11 LEU A  23
ASP A  25
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.59A 4rvjA-5t2zA:
19.9		 4rvjA-5t2zA:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RVJ_B_478B101_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 11 LEU A  23
ASP A  25
ALA A  28
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.62A 4rvjA-5t2zA:
19.9		 4rvjA-5t2zA:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RVJ_B_478B101_2
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 9 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.28A 4rvjB-5t2zA:
19.6		 4rvjB-5t2zA:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RVJ_B_478B101_2
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
GLY A  49
ILE A  50
ILE A  84
 None
 0.51A 4rvjB-5t2zA:
19.6		 4rvjB-5t2zA:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RVJ_D_478D101_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 11 LEU A  23
ASP A  25
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
 None
 0.57A 4rvjC-5t2zA:
19.9		 4rvjC-5t2zA:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RVJ_D_478D101_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 11 LEU A  23
ASP A  25
ALA A  28
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.61A 4rvjC-5t2zA:
19.9		 4rvjC-5t2zA:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RVJ_D_478D101_2
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 9 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.28A 4rvjD-5t2zA:
19.7		 4rvjD-5t2zA:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RVJ_D_478D101_2
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
GLY A  49
ILE A  50
ILE A  84
 None
 0.51A 4rvjD-5t2zA:
19.7		 4rvjD-5t2zA:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5J_A_017A201_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.20A 5e5jA-5t2zA:
20.3		 5e5jA-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5J_A_017A201_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
 0.31A 5e5jA-5t2zA:
20.3		 5e5jA-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5K_B_017B201_2
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.41A 5e5kB-5t2zA:
20.1		 5e5kB-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KQX_A_ROCA101_2
(PROTEASE E35D-SQV)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 9 ARG A   8
LEU A  23
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.54A 5kqxB-5t2zA:
20.0		 5kqxB-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KQY_B_017B101_1
(PROTEASE E35D-DRV)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 LEU A  23
ALA A  28
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.43A 5kqyA-5t2zA:
20.0		 5kqyA-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KQY_B_017B101_2
(PROTEASE E35D-DRV)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 7 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
 0.35A 5kqyB-5t2zA:
20.2		 5kqyB-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR0_A_478A101_1
(PROTEASE E35D-APV)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 ALA A  28
ASP A  30
ILE A  47
PRO A  81
ILE A  84
 None
 0.66A 5kr0A-5t2zA:
20.0		 5kr0A-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR0_A_478A101_1
(PROTEASE E35D-APV)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 9 ALA A  28
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.58A 5kr0A-5t2zA:
20.0		 5kr0A-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR0_A_478A101_2
(PROTEASE E35D-APV)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 9 LEU A  23
GLY A  27
ALA A  28
ASP A  30
VAL A  32
GLY A  49
ILE A  50
 None
 0.42A 5kr0B-5t2zA:
20.0		 5kr0B-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR1_B_017B101_1
(PROTEASE PR5-DRV)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 LEU A  23
ALA A  28
ASP A  30
ILE A  47
GLY A  49
ILE A  50
 None
 0.82A 5kr1A-5t2zA:
19.6		 5kr1A-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR1_B_017B101_1
(PROTEASE PR5-DRV)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 LEU A  23
ASP A  30
ILE A  47
GLY A  49
ILE A  50
ILE A  84
 None
 0.46A 5kr1A-5t2zA:
19.6		 5kr1A-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR2_A_ROCA101_1
(PROTEASE PR5-SQV)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 9 ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
THR A  80
 None
 0.70A 5kr2A-5t2zA:
19.1		 5kr2A-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR2_A_ROCA101_1
(PROTEASE PR5-SQV)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 9 ALA A  28
ASP A  29
ASP A  30
ILE A  47
THR A  80
PRO A  81
 None
 0.53A 5kr2A-5t2zA:
19.1		 5kr2A-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR2_A_ROCA101_2
(PROTEASE PR5-SQV)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 ALA A  28
ASP A  30
ILE A  47
GLY A  49
ILE A  50
ILE A  84
 None
 0.76A 5kr2B-5t2zA:
19.7		 5kr2B-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR2_A_ROCA101_2
(PROTEASE PR5-SQV)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 ARG A   8
ALA A  28
ASP A  30
ILE A  47
GLY A  49
ILE A  84
 None
 1.06A 5kr2B-5t2zA:
19.7		 5kr2B-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR2_A_ROCA101_2
(PROTEASE PR5-SQV)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 ARG A   8
LEU A  23
ASP A  30
ILE A  47
GLY A  49
ILE A  84
 None
 0.94A 5kr2B-5t2zA:
19.7		 5kr2B-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR2_A_ROCA101_2
(PROTEASE PR5-SQV)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 11 LEU A  23
ASP A  30
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.63A 5kr2B-5t2zA:
19.7		 5kr2B-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR2_C_ROCC101_1
(PROTEASE PR5-SQV)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 9 ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
THR A  80
 None
 0.70A 5kr2C-5t2zA:
19.2		 5kr2C-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR2_C_ROCC101_1
(PROTEASE PR5-SQV)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 9 ALA A  28
ASP A  29
ASP A  30
ILE A  47
THR A  80
PRO A  81
 None
 0.67A 5kr2C-5t2zA:
19.2		 5kr2C-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR2_C_ROCC101_2
(PROTEASE PR5-SQV)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 9 ARG A   8
LEU A  23
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.44A 5kr2D-5t2zA:
20.1		 5kr2D-5t2zA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5T8H_B_478B401_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 GLY A  27
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.55A 5t8hA-5t2zA:
20.1		 5t8hA-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5T8H_B_478B401_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
 0.40A 5t8hA-5t2zA:
20.1		 5t8hA-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DGX_A_017A101_0
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.18A 6dgxA-5t2zA:
20.0		 6dgxA-5t2zA:
80.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DGX_A_017A101_0
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
ILE A  84
 None
 0.39A 6dgxA-5t2zA:
20.0		 6dgxA-5t2zA:
80.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DGX_A_017A101_0
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 LEU A  23
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.50A 6dgxA-5t2zA:
20.0		 6dgxA-5t2zA:
80.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DGX_A_017A101_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  30
LEU A  76
PRO A  81
ILE A  84
 None
 0.57A 6dgxB-5t2zA:
19.5		 6dgxB-5t2zA:
80.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DGX_A_017A101_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 LEU A  23
ASP A  25
ALA A  28
VAL A  32
GLY A  49
ILE A  50
LEU A  76
PRO A  81
ILE A  84
 None
 0.48A 6dgxB-5t2zA:
19.5		 6dgxB-5t2zA:
80.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH0_A_017A101_0
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.18A 6dh0A-5t2zA:
20.0		 6dh0A-5t2zA:
80.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH0_A_017A101_0
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
 None
 0.47A 6dh0A-5t2zA:
20.0		 6dh0A-5t2zA:
80.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH0_A_017A101_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
LEU A  76
PRO A  81
 None
 0.52A 6dh0B-5t2zA:
19.6		 6dh0B-5t2zA:
80.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH0_A_017A101_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  49
ILE A  50
LEU A  76
PRO A  81
 None
 0.37A 6dh0B-5t2zA:
19.6		 6dh0B-5t2zA:
80.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH3_A_017A101_0
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.18A 6dh3A-5t2zA:
20.2		 6dh3A-5t2zA:
80.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH3_A_017A101_0
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
ILE A  84
 None
 0.39A 6dh3A-5t2zA:
20.2		 6dh3A-5t2zA:
80.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH3_A_017A101_0
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
GLY A  27
VAL A  32
GLY A  49
ILE A  50
PRO A  81
 None
 0.59A 6dh3A-5t2zA:
20.2		 6dh3A-5t2zA:
80.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH3_A_017A101_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 None
 0.45A 6dh3B-5t2zA:
17.3		 6dh3B-5t2zA:
80.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH3_A_017A101_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.48A 6dh3B-5t2zA:
17.3		 6dh3B-5t2zA:
80.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH6_A_017A104_0
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  84
 None
 0.42A 6dh6A-5t2zA:
20.0		 6dh6A-5t2zA:
78.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH6_A_017A104_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
LEU A  76
PRO A  81
ILE A  84
 None
 0.55A 6dh6B-5t2zA:
19.6		 6dh6B-5t2zA:
78.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH6_A_017A104_1
(PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
ILE A  47
GLY A  49
LEU A  76
PRO A  81
ILE A  84
 None
 0.45A 6dh6B-5t2zA:
19.6		 6dh6B-5t2zA:
78.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DIF_B_TPVB201_0
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		11 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.57A 6difA-5t2zA:
20.2		 6difA-5t2zA:
80.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DIF_B_TPVB201_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ILE A  47
ILE A  50
ILE A  84
 None
 0.47A 6difB-5t2zA:
20.0		 6difB-5t2zA:
80.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DIF_B_TPVB201_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
ILE A  47
GLY A  49
ILE A  50
ILE A  84
 None
 0.48A 6difB-5t2zA:
20.0		 6difB-5t2zA:
80.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DIF_B_TPVB201_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
 None
 0.60A 6difB-5t2zA:
20.0		 6difB-5t2zA:
80.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DIL_B_TPVB201_0
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		11 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
 None
 0.58A 6dilA-5t2zA:
20.0		 6dilA-5t2zA:
78.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DIL_B_TPVB201_0
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
 None
 1.42A 6dilA-5t2zA:
20.0		 6dilA-5t2zA:
78.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DJ1_B_AB1B201_0
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.50A 6dj1A-5t2zA:
20.1		 6dj1A-5t2zA:
80.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DJ1_B_AB1B201_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  30
ILE A  50
PRO A  81
 None
 0.60A 6dj1B-5t2zA:
20.2		 6dj1B-5t2zA:
80.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DJ1_B_AB1B201_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
 None
 0.54A 6dj1B-5t2zA:
20.2		 6dj1B-5t2zA:
80.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DJ2_B_AB1B201_0
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 10 ASP A  25
ALA A  28
ASP A  29
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.55A 6dj2A-5t2zA:
20.0		 6dj2A-5t2zA:
78.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DJ2_B_AB1B201_0
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 1.32A 6dj2A-5t2zA:
20.0		 6dj2A-5t2zA:
78.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DJ2_B_AB1B201_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  50
PRO A  81
 None
 0.53A 6dj2B-5t2zA:
20.0		 6dj2B-5t2zA:
78.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DJ2_B_AB1B201_1
(HIV-1 PROTEASE)		 5t2z PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
 None
 0.54A 6dj2B-5t2zA:
20.0		 6dj2B-5t2zA:
78.75